Targeting extracellular matrix molecules for the treatment of cancer
2011
Abstract
The present invention relates to an agent able to block a cancer supportive function of a fasciclin protein family member and to pharmaceutical compositions containing the same.
Details
Title
Targeting extracellular matrix molecules for the treatment of cancer
Author(s)
Huelsken, Joerg ; Malanchi, Ilaria
Date
2011
Keywords
Note
Alternative title(s) :
(fr) Molécules de matrice extracellulaire de ciblage pour le traitement du cancer
Other identifier(s)
EPO Family ID: 43063451
Patent number(s)
WO2011024114 (A1)
Laboratories
UPHUELSKEN
TTO
TTO
Record Appears in
Scientific production and competences > SV - School of Life Sciences > ISREC - Swiss Institute for Experimental Cancer Research > UPHUELSKEN - Prof. Huelsken Group
Scientific production and competences > Non-academic units > TTO - Technology Transfer Office
Work produced at EPFL
Patents
Scientific production and competences > Non-academic units > TTO - Technology Transfer Office
Work produced at EPFL
Patents
Record creation date
2015-09-22